Jennifer J. Rhodes

2023

In 2023, Jennifer J. Rhodes earned a total compensation of $1.4M as former Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Corporate Secretary at Elicio Therapeutics, a 77% increase compared to previous year.

Compensation breakdown

Bonus$440,840
Salary$222,257
Other$702,762
Total$1,365,859

Rhodes received $702.8K in other compensation, accounting for 51% of the total pay in 2023.

Rhodes also received $440.8K in bonus and $222.3K in salary.

Rankings

In 2023, Jennifer J. Rhodes' compensation ranked 878th out of 3,006 executives tracked by ExecPay. In other words, Rhodes earned more than 70.8% of executives.

ClassificationRankingPercentile
All
878
out of 3,006
71st
Division
Manufacturing
514
out of 1,650
69th
Major group
Chemicals And Allied Products
351
out of 918
62nd
Industry group
Drugs
341
out of 881
61st
Industry
Pharmaceutical Preparations
231
out of 637
64th
Source: SEC filing on September 27, 2024.

Rhodes' colleagues

We found four more compensation records of executives who worked with Jennifer J. Rhodes at Elicio Therapeutics in 2023.

2023

Jay Venkatesan

Elicio Therapeutics

Chief Executive Officer

2023

Brian Piekos

Elicio Therapeutics

Chief Financial Officer

2023

Robert Connelly

Elicio Therapeutics

Chief Executive Officer

2023

Christopher Haqq

Elicio Therapeutics

Chief Medical Officer

News

You may also like